ESR1 and breast carcinoma: BCS had significantly greater use of exogenous hormones (p < 0.0001) due to their use of selective estrogen receptor modulators (SERMs) and antineoplastic exogenous hormones (frequently prescribed as part of breast cancer treatment [50]).